The ubiquitin ligase Siah2 and the hypoxia response

Molecular Cancer Research

Volumn 7, Issue 4, 2009, Pages 443-451

  Nakayama, Koh ^b   Qi, Jianfei ^a   Ronai, Ze'ev ^a  

^a BURNHAM INSTITUTE   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN KINASE B; SIAH2 ENZYME; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; SEVEN IN ABSENTIA PROTEINS; SIAH2 PROTEIN, MOUSE;

BREAST TUMOR; CARCINOGENESIS; COMPLEX FORMATION; ENZYME ACTIVITY; HYPOXIA; MELANOMA; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; TUMOR GROWTH; AMINO ACID SEQUENCE; ANIMAL; ANOXIA; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANOXIA; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 65549139358     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0458     Document Type: Short Survey

References (125)

1. Lahiri S, Roy A, Baby SM, Hoshi T, Semenza GL, Prabhakar NR. Oxygen sensing in the body. Prog Biophys Mol Biol 2006;91:249-286, PubMed doi:10.1016/j.pbiomolbio.2005.07.001.
2. Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer 2008;8:967-975, PubMed doi:10.1038/nrc2540.
3. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008;15:678-685, PubMed doi:10.1038/cdd.2008. 21.
4. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005;2005:re12.
5. Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 2000;19:6297-6305, PubMed doi:10.1038/sj.onc.1204012.
6. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res 1999;59:3915-3918, PubMed. (Pubitemid 29393552)
7. Krishnamachary B, Berg-Dixon S, Kelly B, et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003;63:1138-1143, PubMed.
8. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A 2000;97:9082-9087, PubMed doi:10.1073/pnas.97.16.9082.
9. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001;61:6669-6673, PubMed. (Pubitemid 32896483)
10. Ebert BL, Firth JD, Ratcliffe PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem 1995;270:29083-29089, PubMed doi:10.1074/jbc.270.36.21021.
11. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci U S A 1994;91:6496-6500, PubMed doi:10.1073/pnas.91.14.6496.
12. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994;269:23757-23763, PubMed.
13. Graven KK, Yu Q, Pan D, Roncarati JS, Farber HW. Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim Biophys Acta 1999;1447:208-218 (Pubitemid 29494992)
14. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006;3:177-185, PubMed doi:10.1016/j.cmet. 2006.02.002. (Pubitemid 43316523)
15. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006;3:187-197, PubMed doi:10.1016/j.cmet.2006.01.012. (Pubitemid 43316524)
16. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-4613
17. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995;270:13333-13340, PubMed doi:10.1074/jbc.270.22.13333.
18. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 1995;77:638-643
19. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992;12:5447-5454, PubMed.
20. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003;3:347-61, PubMed doi:10.1016/S1535-6108 (03)00085-90 (Pubitemid 38340304)
21. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003;425:307-311, PubMed doi:10.1038/nature01874. (Pubitemid 37158407)
22. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. HIF-2α promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 2007;11:335-347, PubMed doi:10.1016/j.ccr.2007.02.006.
23. Holmquist-Mengelbier L, Fredlund E, Lofstedt T, et al. Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype. Cancer Cell 2006;10:413-423, PubMed doi:10.1016/j.ccr.2006.08.026.
24. Makino Y, Cao R, Svensson K, et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001;414:550-554, PubMed doi:10.1038/35107085.
25. Covello KL, Kehler J, Yu H, et al. HIF-2α regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 2006;20:557-570, PubMed doi:10.1101/gad.1399906.
26. Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 α. Genes Dev 1998;12:149-162, PubMed doi:10.1101/gad.12.2.149.
27. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998;394:485-490, PubMed doi:10.1038/28867.
28. Ryan HE, Lo J, Johnson RS. HIF-1 α is required for solid tumor formation and embryonic vascularization. EMBO J 1998;17:3005-3015, PubMed doi:10.1093/emboj/17.11.3005. (Pubitemid 28254373)
29. Compernolle V, Brusselmans K, Acker T, et al. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002;8:702-710, PubMed.
30. Peng J, Zhang L, Drysdale L, Fong GH. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc Natl Acad Sci U S A 2000;97:8386-8391, PubMed doi:10.1073/pnas.140087397. (Pubitemid 30639682)
31. Scortegagna M, Ding K, Oktay Y, et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet 2003;35:331-340, PubMed doi:10.1038/ng1266.
32. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 1998;12:3320-3324, PubMed doi:10.1101/gad.12.21.3320. (Pubitemid 28520979)
33. Kamura T, Sato S, Iwai K, Czyzyk-Krzeska M, Conaway RC, Conaway JW. Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci U S A 2000;97:10430-10435, PubMed doi:10.1073/pnas.190332597.
34. Ohh M, Park CW, Ivan M, et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat Cell Biol 2000;2:423-427, PubMed doi:10.1038/35017054.
35. Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271-275, PubMed doi:10.1038/20459.
36. Ivan M, Kondo K, Yang H, et al. HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001;292:464-468, PubMed doi:10.1126/science.1059817.
37. Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIFby prolyl hydroxylation. Cell 2001;107:43-54, PubMed doi:10.1016/S0092-8674(01)00507-514
38. Hon WC, Wilson MI, Harlos K, et al. Structural basis for the recognition of hydroxyproline in HIF-1 á by pVHL. Nature 2002;417:975-978, PubMed doi:10.1038/nature00767. (Pubitemid 34716877)
39. Min JH, Yang H, Ivan M, Gertler F, Kaelin WG, Jr., Pavletich NP. Structure of an HIF-1α -pVHL complex: hydroxyproline recognition in signaling. Science 2002;296:1886-1889, PubMed doi:10.1126/science.1073440. (Pubitemid 34596278)
40. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J Biol Chem 1999;274:32631-32637, PubMed doi:10.1074/jbc.274.46.32631.
41. Carbia-Nagashima A, Gerez J, Perez-Castro C, et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α during hypoxia. Cell 2007;131:309-323, PubMed doi:10.1016/j.cell.2007.07.044.
42. Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF1α during hypoxia. Cell 2007;131:584-595, PubMed doi:10.1016/j.cell.2007.08.045. (Pubitemid 350007694)
43. Bae SH, Jeong JW, Park JA, et al. Sumoylation increases HIF-1α stability and its transcriptional activity. Biochem Biophys Res Commun 2004;324:394-400, PubMed doi:10.1016/j.bbrc.2004.09.068.
44. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002;16:1466-1471, PubMed doi:10.1101/gad.991402. (Pubitemid 34686328)
45. Schofield CJ, Ratcliffe PJ. Signalling hypoxia by HIFhydr oxylases. Biochem Biophys Res Commun 2005;338:617-626, PubMed doi:10.1016/j.bbrc.2005.08. 111.
46. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001;294:1337-1340, PubMed doi:10.1126/science.1066373.
47. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 2003;22:4082-4090, PubMed doi:10.1093/emboj/ cdg392. (Pubitemid 37021737)
48. Appelhoff RJ, Tian YM, Raval RR, et al. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 2004;279:38458-38465, PubMed doi:10.1074/jbc.M406026200.
49. Cummins EP, Berra E, Comerford KM, et al. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-β, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A 2006;103:18154-18159, PubMed doi:10.1073/pnas.0602235103.
50. Cockman ME, Lancaster DE, Stolze IP, et al. Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF(F IH). Proc Natl Acad Sci U S A 2006;103:14767-14772, PubMed doi:10.1073/pnas.0606877103.
51. Coleman ML, McDonough MA, Hewitson KS, et al. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J Biol Chem 2007;282:24027-24038, PubMed doi:10.1074/jbc.M704102200.
52. Zheng X, Linke S, Dias JM, et al. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc Natl Acad Sci U S A 2008;105:3368-3373, PubMed doi:10.1073/pnas.0711591105.
53. Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, Fong GH. Placental but not heart defects are associated with elevated hypoxia-inducible factor α levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol 2006;26:8336-8346, PubMed doi:10.1128/MCB.00425-06.
54. Aragones J, Schneider M, Van Geyte K, et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 2008;40:170-180, PubMed doi:10.1038/ng.2007.62.
55. Minamishima YA, Moslehi J, Bardeesy N, Cullen D, Bronson RT, Kaelin WG, Jr. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 2008;111:3236-44, PubMed doi:10.1182/blood-2007- 10-117812.
56. Bishop T, Gallagher D, Pascual A, et al. Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice. Mol Cell Biol 2008;28:3386-3400, PubMed doi:10.1128/MCB.02041-07.
57. Alarcon R, Koumenis C, Geyer RK, Maki CG, Giaccia AJ. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res 1999;59:6046-6051, PubMed. (Pubitemid 30035618)
58. Di Carlo A, De Mori R, Martelli F, Pompilio G, Capogrossi MC, Germani A. Hypoxia inhibits myogenic differentiation through accelerated MyoD degradation. J Biol Chem 2004;279:16332-16338, PubMed doi:10.1074/jbc.M313931200. (Pubitemid 38509329)
59. Taylor CT, Furuta GT, Synnestvedt K, Colgan SP. Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia. Proc Natl Acad Sci U S A 2000;97:12091-12096, PubMed doi:10.1073/pnas.220211797.
60. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998;67:425-479, PubMed doi:10.1146/annurev.biochem.67.1.425. (Pubitemid 28411135)
61. Schnell JD, Hicke L. Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J Biol Chem 2003;278:35857-35860, PubMed doi:10.1074/jbc.R300018200. (Pubitemid 37139902)
62. Reed JC, Ely KR. Degrading liaisons: Siah structure revealed. Nat Struct Biol 2002;9:8-10, PubMed doi:10.1038/nsb0102-8.
63. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 1997;277:1669-1672, PubMed doi:10.1126/science.277.5332.1669. (Pubitemid 27446230)
64. Tang AH, Neufeld TP, Kwan E, Rubin GM. PHYL acts to down-regulate TTK88, a transcriptional repressor of neuronal cell fates, by a SINA-dependent mechanism. Cell 1997;90:459-67, PubMed doi:10.1016/S0092-8674(00)80506-80511 (Pubitemid 27347236)
65. Della NG, Senior PV, Bowtell DD. Isolation and characterisation of murine homologues of the Drosophila seven in absentia gene (sina). Development 1993;117:1333-1343, PubMed.
66. Zhang J, Guenther MG, Carthew RW, Lazar MA. Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev 1998;12:1775-1780, PubMed doi:10.1101/gad.12.12.1775. (Pubitemid 28304330)
67. Matsuzawa SI, Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol Cell 2001;7:915-26, PubMed doi:10.1016/S1097-2765([01])00242-248
68. Habelhah H, Laine A, Erdjument-Bromage H, et al. Regulation of 2-oxoglutarate (α-ketoglutarate) dehydrogenase stability by the RING finger ubiquitin ligase Siah. J Biol Chem 2004;279:53782-53788, PubMed doi:10.1074/jbc.M410315200.
69. Habelhah H, Frew IJ, Laine A, et al. Stress-induced decrease in TRAF2 stability is mediated by Siah2. EMBO J 2002;21:5756-5765, PubMed doi:10.1093/emboj/cdf576.
70. Johnsen SA, Subramaniam M, Monroe DG, Janknecht R, Spelsberg TC. Modulation of transforming growth factor β (TGFβ)/Smad transcriptional responses through targeted degradation of TGFβ-inducible early gene-1 by human seven in absentia homologue. J Biol Chem 2002;277:30754-30759, PubMed doi:10.1074/jbc.M204812200.
71. Li S, Xu C, Carthew RW. Phyllopod acts as an adaptor protein to link the sina ubiquitin ligase to the substrate protein tramtrack. Mol Cell Biol 2002;22:6854-6865, PubMed doi:10.1128/MCB.22.19.6854-6865.2002.
72. Frew IJ, Hammond VE, Dickins RA, et al. Generation and analysis of Siah2 mutant mice. Mol Cell Biol 2003;23:9150-9161, PubMed doi:10.1128/MCB.23.24.9150- 9161.2003.
73. Nakayama K, Frew IJ, Hagensen M, et al. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia. Cell 2004;117:941-952, PubMed doi:10.1016/j.cell.2004.06. 001.
74. Yu AY, Shimoda LA, Iyer NV, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J Clin Invest 1999;103:691-696, PubMed doi:10.1172/JCI5912.
75. Nakayama K, Gazdoiu S, Abraham R, Pan ZQ, Ronai Z. Hypoxia-induced assembly of prolyl hydroxylase PHD3 into complexes: implications for its activity and susceptibility for degradation by the E3 ligase Siah2. Biochem J 2007;401:217-226, PubMed doi:10.1042/BJ20061135. (Pubitemid 46114615)
76. Rantanen K, Pursiheimo J, Hogel H, Himanen V, Metzen E, Jaakkola PM. Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation. Mol Biol Cell 2008;19:2231-40, PubMed doi:10.1091/mbc.E07-11-1124.
77. Seta KA, Spicer Z, Yuan Y, Lu G, Millhorn DE. Responding to hypoxia: lessons from a model cell line. Sci STKE 2002;2002:RE11.
78. Kulisz A, Chen N, Chandel NS, Shao Z, Schumacker PT. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am J Physiol Lung Cell Mol Physiol 2002;282:L1324-9, PubMed. (Pubitemid 34654589)
79. Emerling BM, Platanias LC, Black E, Nebreda AR, Davis RJ, Chandel NS. Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol Cell Biol 2005;25:4853-4862, PubMed doi:10.1128/MCB.25.12.4853-4862.2005. (Pubitemid 40781087)
80. Khurana A, Nakayama K, Williams S, Davis RJ, Mustelin T, Ronai Z. Regulation of the ring finger E3 ligase Siah2 by p38 MAPK. J Biol Chem 2006;281:35316-35326, PubMed doi:10.1074/jbc.M606568200. (Pubitemid 46036570)
81. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002;277:38205-38211, PubMed doi:10.1074/jbc.M203781200. (Pubitemid 35154674)
82. Zundel W, Schindler C, Haas-Kogan D, et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000;14:391-396
83. House CM, Hancock NC, Moller A, et al. Elucidation of the substrate binding site of Siah ubiquitin ligase. Structure 2006;14:695-701, PubMed doi:10.1016/j.str.2005.12.013.
84. Qi J, Nakayama K, Gaitonde S, et al. The ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and -independent pathways. Proc Natl Acad Sci U S A 2008;105:16713-16718, PubMed doi:10.1073/pnas.0804063105.
85. Liao D, Corle C, Seagroves TN, Johnson RS. Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res 2007;67:563-72, PubMed doi:10.1158/0008-5472.CAN-06-2701. (Pubitemid 46192193)
86. Shaw AT, Meissner A, Dowdle JA, et al. Sprouty-2 regulates oncogenic Kras in lung development and tumorigenesis. Genes Dev 2007;21:694-707, PubMed doi:10.1101/gad.1526207.
87. Nadeau RJ, Toher JL, Yang X, Kovalenko D, Friesel R. Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2. J Cell Biochem 2007;100:151-160, PubMed doi:10.1002/jcb.21040.
88. Schmidt RL, Park CH, Ahmed AU, et al. Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue. Cancer Res 2007;67:11798-810, PubMed doi:10.1158/0008-5472.CAN-06-4471.
89. Möller A, House CM, Wong CS, et al. Inhibition of Siah ubiquitin ligase function. Oncogene 2008;28:289-296
90. Zhai H, Shi Y, Jin H, et al. Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey. J Histochem Cytochem 2008;56:765-772, PubMed doi:10.1369/jhc.2008.950519.
91. Sun S, Ning X, Liu J, et al. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. Biochem Biophys Res Commun 2007;356:864-871, PubMed doi:10.1016/j.bbrc.2007.03.080.
92. Arsham AM, Howell JJ, Simon MC. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem 2003;278:29655-29660, PubMed doi:10.1074/jbc. M212770200.
93. Lai JC, White BK, Buerstatte CR, Haddad GG, Novotny EJ, Jr., Behar KL. Chronic hypoxia in development selectively alters the activities of key enzymes of glucose oxidative metabolism in brain regions. Neurochem Res 2003;28:933-40, PubMed doi:10.1023/A:1023235712524.
94. Matsuzawa S, Takayama S, Froesch BA, Zapata JM, Reed JC. p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1. EMBO J 1998;17:2736-2747, PubMed doi:10.1093/emboj/17.10. 2736. (Pubitemid 28227120)
95. Mekhail K, Khacho M, Carrigan A, Hache RR, Gunaratnam L, Lee S. Regulation of ubiquitin ligase dynamics by the nucleolus. J Cell Biol 2005;170:733-744, PubMed doi:10.1083/jcb.200506030. (Pubitemid 41242106)
96. Zhang J, Guenther MG, Carthew RW, Lazar MA. Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev 1998;12:1775-1780, PubMed doi:10.1101/gad.12.12.1775. (Pubitemid 28304330)
97. Tanikawa J, Ichikawa-Iwata E, Kanei-Ishii C, et al. p53 suppresses the c-Myb-induced activation of heat shock transcription factor 3. J Biol Chem 2000;275:15578-15585, PubMed doi:10.1074/jbc.M000372200. (Pubitemid 30337293)
98. Boehm J, He Y, Greiner A, Staudt L, Wirth T. Regulation of BOB.1/OBF.1 stability by SIAH. EMBO J 2001;20:4153-4162, PubMed doi:10.1093/emboj/20.15. 4153. (Pubitemid 32751831)
99. Tiedt R, Bartholdy BA, Matthias G, Newell JW, Matthias P. The RING finger protein Siah-1 regulates the level of the transcriptional coactivator OBF-1. EMBO J 2001;20:4143-4152, PubMed doi:10.1093/emboj/20.15.4143. (Pubitemid 32751830)
100. Fanelli M, Fantozzi A, De Luca P, et al. The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome. J Biol Chem 2004;279:5374-5379, PubMed doi:10.1074/jbc.M306407200.
101. Germani A, Prabel A, Mourah S, et al. SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway. Oncogene 2003;22:8845-8851, PubMed doi:10.1038/sj.onc.1206994.
102. Johnsen SA, Subramaniam M, Monroe DG, Janknecht R, Spelsberg TC. Modulation of transforming growth factor β (TGFβ)/Smad transcriptional responses through targeted degradation of TGFβ-inducible early gene-1 by human seven in absentia homologue. J Biol Chem 2002;277:30754-30759, PubMed doi:10.1074/jbc.M204812200.
103. Habelhah H, Laine A, Erdjument-Bromage H, et al. Regulation of 2-oxoglutarate (α-ketoglutarate) dehydrogenase stability by the RING finger ubiquitin ligase Siah. J Biol Chem 2004;279:53782-53788, PubMed doi:10.1074/jbc.M410315200.
104. Nakayama K, Frew IJ, Hagensen M, et al. Siah2 regulates stability of prolylhydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia. Cell 2004;117:941-952, PubMed doi:10.1016/j.cell.2004.06. 001.
105. Fukuba H, Takahashi T, Jin HG, Kohriyama T, Matsumoto M. Abundance of aspargynyl-hydroxylase FIH is regulated by Siah-1 under normoxic conditions. Neurosci Lett 2008;433:209-214, PubMed doi:10.1016/j.neulet.2007.12.069.
106. Matsuzawa SI, Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol Cell 2001;7:915-26, PubMed doi:10.1016/S1097-2765(01)00242-248
107. Hu G, Zhang S, Vidal M, Baer JL, Xu T, Fearon ER. Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome pathway. Genes Dev 1997;11:2701-2714, PubMed doi:10.1101/gad.11.20.2701. (Pubitemid 27452393)
108. Bursen A, Moritz S, Gaussmann A, Dingermann T, Marschalek R. Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?. Oncogene 2004;23:6237-6249, PubMed doi:10.1038/sj.onc. 1207837. (Pubitemid 39215294)
109. Oliver PL, Bitoun E, Clark J, Jones EL, Davies KE. Mediation of Af4 protein function in the cerebellum by Siah proteins. Proc Natl Acad Sci U S A 2004;101:14901-14906, PubMed doi:10.1073/pnas.0406196101. (Pubitemid 39410772)
110. Liani E, Eyal A, Avraham E, et al. Ubiquitylation of synphilin-1 and α-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Proc Natl Acad Sci U S A 2004;101:5500-5505, PubMed doi:10.1073/pnas.0401081101.
111. Nagano Y, Yamashita H, Takahashi T, et al. Siah-1 facilitates ubiquitination and degradation of synphilin-1. J Biol Chem 2003;278:51504-51514, PubMed doi:10.1074/jbc.M306347200.
112. Wheeler TC, Chin LS, Li Y, Roudabush FL, Li L. Regulation of synaptophysin degradation by mammalian homologues of seven in absentia. J Biol Chem 2002;277:10273-10282, PubMed doi:10.1074/jbc.M107857200.
113. Moriyoshi K, Iijima K, Fujii H, Ito H, Cho Y, Nakanishi S. Seven in absentia homolog 1A mediates ubiquitination and degradation of group 1 metabotropic glutamate receptors. Proc Natl Acad Sci U S A 2004;101:8614-8619, PubMed doi:10.1073/pnas.0403042101. (Pubitemid 38745819)
114. Relaix F, Wei X, Li W, et al. Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis. Proc Natl Acad Sci U S A 2000;97:2105-2110, PubMed doi:10.1073/pnas.040378897.
115. Germani A, Bruzzoni-Giovanelli H, Fellous A, Gisselbrecht S, Varin-Blank N, Calvo F. SIAH-1 interacts with α-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis. Oncogene 2000;19:5997-6006, PubMed doi:10.1038/sj.onc.1204002. (Pubitemid 32039375)
116. Susini L, Passer BJ, Amzallag-Elbaz N, et al. Siah-1 binds and regulates the function of Numb. Proc Natl Acad Sci U S A 2001;98:15067-15072, PubMed doi:10.1073/pnas.261571998.
117. Venables JP, Dalgliesh C, Paronetto MP, et al. SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasome. Hum Mol Genet 2004;13:1525-1534, PubMed doi:10.1093/hmg/ddh165.
118. Li S, Li Y, Carthew RW, Lai ZC. Photoreceptor cell differentiation requires regulated proteolysis of the transcriptional repressor Tramtrack. Cell 1997;90:469-78, PubMed doi:10.1016/S0092-8674(00)80507-80513 (Pubitemid 27347237)
119. Tang AH, Neufeld TP, Kwan E, Rubin GM. PHYL acts to down-regulate TTK88, a transcriptional repressor of neuronal cell fates, by a SINA-dependent mechanism. Cell 1997;90:459-67, PubMed doi:10.1016/S0092-8674(00)80506-80511 (Pubitemid 27347236)
120. Liu J, Stevens J, Rote CA, et al. Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 2001;7:927-36, PubMed doi:10.1016/S1097-2765(01)00241-246
121. Germani A, Romero F, Houlard M, et al. hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways. Mol Cell Biol 1999;19:3798-3807, PubMed. (Pubitemid 29193839)
122. Matsuzawa S, Takayama S, Froesch BA, Zapata JM, Reed JC. p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1. EMBO J 1998;17:2736-2747, PubMed doi:10.1093/emboj/17.10. 2736. (Pubitemid 28227120)
123. Park TJ, Hamanaka H, Ohshima T, Watanabe N, Mikoshiba K, Nukina N. Inhibition of ubiquitin ligase Siah-1A by disabled-1. Biochem Biophys Res Commun 2003;302:671-8, PubMed doi:10.1016/S0006-291X(03)00247-X. (Pubitemid 36294025)
124. Okabe H, Satoh S, Furukawa Y, et al. Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res 2003;63:3043-3048
125. Li S, Xu C, Carthew RW. Phyllopod acts as an adaptor protein to link the sina ubiquitin ligase to the substrate protein tramtrack. Mol Cell Biol 2002;22:6854-6865, PubMed doi:10.1128/MCB.22.19.6854-6865.2002.